Viewing Study NCT06163352



Ignite Creation Date: 2024-05-06 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06163352
Status: COMPLETED
Last Update Posted: 2023-12-21
First Post: 2023-11-14

Brief Title: The Effect of Vasopressor on Pressure Injury Development
Sponsor: Koç University
Organization: Koç University

Study Overview

Official Title: The Effect of Vasopressor Agents on Pressure Injury Development in Intensive Care Patients
Status: COMPLETED
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Background Vasopressors are life-saving agents that increase mean arterial pressure The pharmacodynamic features of these agents and previous studies suggest that vasopressors may be an essential risk factor in developing pressure injuries

Objective This study aimed to examine the effect of vasopressors in medical-surgical intensive care patients on pressure injury development

Design and Settings This retrospective and correlational study was conducted between March 2021- May 2022 The electronic patient data were obtained from 148 surgical and medical patients treated with vasopressor agents in the intensive care unit Data on patients demographic and clinical characteristics were evaluated using descriptive statistical methods number percentage mean standard deviation A logistic regression model was established to estimate the dependent variable development of pressure injury with the independent variables
Detailed Description: There is a need for studies in which vasopressor drugs are discussed in detail and the risk factors that may cause pressure injury development in patients Therefore this study aims to examine vasopressors effect on PI development among patients in intensive care units

MATERIALS and METHODS Design This retrospective and correlational study examined the effect of vasopressors on pressure injury development in medical and surgical intensive care patients The Consolidated Standards of Reporting Trials CONSORT statement guided this study Boutron et al 2008 Ethics Approval The Ethics Committee of Koç University approved the study 2022365IRB1155 and institutional permission was obtained

Sample and Settings The study included all medical-surgical adult critical patients hospitalized in the 16-bed Adult Intensive Care Unit ICU It is a 3rd level ICU where medical and surgical patients receive life support treatments and care at the highest level The study was conducted at XXX Hospital between May 2020 and March 2021 The study population consisted of 900 patients hospitalized in the ICU between these dates The sample consisted of all medical and surgical patients over 18 who do not have pressure injury upon admission and received one or more vasopressor agent infusions norepinephrine epinephrine phenylephrine dopamine adrenaline dobutamine for at least 48 hours during their stay in the ICU Nurses checked skin and the existence of PI daily They recorded their findings during the stay of the patients in the Pressure Wound Prevention Evaluation and Follow-up Form within 24 hours Prevention diagnosis staging of pressure injury and implementation of interventions appropriate to the stage were performed per this protocol If pressure injury develops in patients it is evaluated and staged and appropriate interventions are decided for each patient under the leadership of the wound care nurse After the first evaluation of the PI by the wound care nurse the wound care nurse continued to evaluate patients wounds daily In line with all these approaches it aimed to provide standardization for managing pressure injury prevention staging and implementation of interventions and to provide the highest reliability between nurses evaluations and interventions In line with this protocol In the ICU barrier cream or spray and gel adhesive dressings were used on the pressure areas of the body parts for prevention and support skin surfaces were used to distribute the pressure by the pressure injury protocol

Furthermore skin hygiene and nourishing applying gel adhesive dressing on pressure areas repositioning of sedated patients every 2 hours frequent position changes of unsedated patients heel and head elevation and nutritional assessment of patients were implemented to prevent PI The European Pressure Ulcer Advisory Panel and the National Pressure Ulcer Advisory Panel Pressure Ulcers Classification System used by the nurses to stage the pressure injury of the accordingly Stage I Nonblanchable erythema of intact skin stage II Partial-thickness skin loss with exposed dermis stage III Full-thickness skin loss stage IV Full-thickness skin and tissue loss unstageable stage Obscured full-thickness skin and tissue loss and suspected deep tissue injury Persistent nonblanchable deep red maroon or purple discoloration Edsberg Black 2016 All nurses working in the ICU attended the orientation training program before starting to work in the ICU and received formal training on pressure injury prevention diagnosis staging and planning and implementation of appropriate interventions within the scope of this program

Data Collection Data were obtained retrospectively from the electronic health record system by the researchers The authors developed a data collection form to collect data Data regarding the demographic characteristics included sex age and comorbid diseases Clinical data included the diagnosis for ICU admission medicalsurgical mechanical ventilation MV requirement and duration of MV the total length of stay in ICU the types of vasopressors used the mean daily dose and the duration of infusion of the vasopressor agents were recorded The other PI risk factors age65 receiving chemotherapy cachexia being at the end of life circulation problems dehydration and loss of sensation were also determined The data regarding the PI were obtained from the Pressure Wound Evaluation and Follow-up Form used by ICU nurses Furthermore the location stage based on the National Pressure Injury Advisory Panel staging system and the time for PI development were between initiation of vasopressor vasopressor and pressure injury In the case of PI development in patients PI was staged under the leadership of the wound care nurse to provide standardization for pressure injury prevention diagnosis staging and the implementation of appropriate interventions in all patients

Statistical Analysis Data was analyzed using SPSS Statistical Package for Social Sciences for Windows 280 program IBM Corp Armonk NY USA Data on patients demographic and clinical characteristics were evaluated using descriptive statistical methods number percentage mean standard deviation A logistic regression model was established to estimate the dependent variable development of PI with the independent variables The significance was evaluated at p05 Only statistically significant variables found at the 005 level were included in the model table the statistically unsignificant variables were removed from the model and the final model was decided Using the logistic regression model and if the R2 value is 589 the minimum number of samples was 97 at the 95 confidence 95 power level and 5 standard error Therefore 148 participants were enough for regression analysis

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None